Just as there’s a science to the tests your physicians select, there’s a methodology to improve lab productivity and efficiency while simultaneously growing clinical support and patient access. Through our work with hundreds of health systems across the country, we have developed a set of best practices for managing the challenges you’re facing right now. We can collaborate with you to help achieve your objectives, whether it's addressing the demand for more esoteric testing, a shrinking labor force, or escalating capital expenditures and supply costs. \r\n"}}" id="text-23062a461b" class="cmp-text">
正如您的醫生選擇的科學就一樣,有一種方法可以提高實驗室生產力和效率,同時增長臨床支持和患者訪問。通過我們與全國各地數百人的工作,我們開發了一係列最佳實踐,以管理您現在所麵臨的挑戰。我們可以與您合作,幫助實現您的目標,無論是如何解決對更深層測試的需求,萎縮勞動力,或升級資本支出和供應費用。
Decrease budget requirements by 8%-15%1 while increasing quality and access\r\n"}}" id="text-fdfe5dac69" class="cmp-text">
減少預算要求8%-15%1同時提高質量和訪問
By pairing twin strategies of lab management and lab stewardship you can accelerate the lab as a center of excellence that supports your health system’s clinical and businesses equally well. \r\n
Our clinical integration solutions help you:
\r\n
\r\n- Increase revenue by performing reference testing at market competitive prices
\r\n- Leverage supply and equipment pricing to provide greater savings
\r\n- Move low volume, high cost, less time-sensitive tests to a local Quest lab
\r\n- Evaluate full-time employee requirements
\r\n- Drive efficiencies with quality assurance, increased productivity, and improved inspection readiness
\r\n
\r\n
At the same time, you can also decrease unnecessarya test orders (and associated downstream care), and make more informed and proactive data-driven decisions about test over and under utilization across your organization. With this insight, you can focus your resources where they will help the most.
\r\n
a The term “unnecessary” refers to testing ordered for a patient whose symptoms and/or condition may not support the need for the testing under generally accepted third-party clinical guidelines. Quest Diagnostics identification of potential unnecessary testing is intended as a guide to assist providers in identifying potentially problematic ordering patterns and is not intended to replace a treating provider’s medical judgment, based upon evaluation of the patient.
\r\n
1 Data on file. Quest Diagnostics, 2021.
\r\n
\r\n"}}" id="text-300bbb2ff0" class="cmp-text">
通過配對實驗室管理和實驗室管理的雙策略,您可以將實驗室加速為支持您的健康係統臨床和企業同樣良好的卓越中心。
我們的臨床集成解決方案可幫助您:
- 通過以市場競爭價格進行參考測試增加收入
- 利用供應和設備定價提供更高的儲蓄
- 向本地Quest實驗室移動低量,高成本,時間較少的時間敏感測試
- 評估全職員工要求
- 推動質量保證,提高生產率和改進檢查準備的效率
與此同時,您也可以減少不必要的一種測試訂單(以及相關的下遊護理),並在組織中進行有關測試的更新和主動數據驅動的決策。通過這種洞察力,您可以將您的資源集中在最佳位置。
術語“不必要”是指針對患者的檢測,其症狀和/或條件可能不支持在普遍接受的第三方臨床指南下對測試的需要。Quest Diagnostics識別潛在的不必要的測試旨在作為幫助提供商識別潛在問題的訂購模式的指南,並且不旨在基於患者的評估來取代治療提供商的醫學判斷。
1個文件上的數據。Quest Diagnostics,2021。